Introduction
The recording of vestibular evoked myogenic potentials is emerging as a useful tool in clinical vestibular practice. Clinical and experimental studies have suggested that vestibular evoked myogenic potentials are generated by saccular afferents in response to loud acoustic stimuli, and may be recorded by surface electrodes on a tonically contracted sternocleidomastoid muscle. 2, 3 The putative pathway for ipsilateral vestibular evoked myogenic potential is the saccule, inferior vestibular nerve, lateral vestibular nucleus, lateral vestibulospinal tract and the sternocleidomastoid muscle (Figure 1 ).
Ménière's disease is an inner-ear disorder with an entirely unpredictable clinical course. The pathophysiology is unknown, although endolymphatic hydrops is believed to be the main histopathological correlate. The disease in its typical form is characterised by acute phases (exacerbation), with attacks of aural fullness, vertigo, tinnitus and hearing loss, separated by variable periods of remission (stable phase). The underlying mechanism for such a clinical course is unclear. Furthermore, at present, several tests are used to characterise Ménière's disease, including the caloric test, electronystagmography, electrocochleography and osmotic tests. However, results are highly variable, such that no one test is diagnostic. Moreover, all these tests may cause some degree of discomfort.
Vestibular evoked myogenic potentials are thought to provide specific information about the saccule, which, according to histological studies, is the most common site of morphological alteration in the vestibular labyrinth. 4, 5 Thus, the recording of vestibular evoked myogenic potentials could be a suitable test for Mé niè re's disease, as it is easy to perform, non-invasive and well tolerated. It is therefore anticipated that vestibular evoked myogenic potentials could be used in cases of Mé niè re's disease to: aid understanding of the pathophysiology; aid diagnosis (particularly regarding early detection of contralateral ear involvement); and monitor the clinical course of the disease.
There have been a number of reports on vestibular evoked myogenic potentials in Mé niè re's disease, with variable results.
De Waele et al. 6 studied 59 patients with Mé niè re's disease and reported absent vestibular evoked myogenic potentials (in response to clicks) in 54 per cent of patients; this result correlated with the degree of low frequency hearing loss and poor postural performance, but not with canal paresis.
Seo et al. 7 reported a case of saccular hydrops in a patient presenting with non-rotatory disequilibrium, in which a depressed vestibular evoked myogenic potential amplitude recovered to normal after furosemide administration. The same group 8 subsequently demonstrated an increase in p13-n23 amplitude in seven of 18 cases and the reappearance of vestibular evoked myogenic potentials in three out of seven cases after furosemide loading. These results suggest that reversal of reflex attenuation is due to reduction of saccular hydrops following diuresis. However, in those in whom vestibular evoked myogenic potentials remained absent after furosemide loading, severe hydrops might have caused irreversible saccular degeneration.
Detection of either absent or reduced vestibular evoked myogenic potential amplitudes has been widely reported. 9 -12 Kuo et al. 13 reported abnormal vestibular evoked myogenic potentials (absent or depressed) in eight out of 12 Mé niè re's disease patients within 24 hours of an acute attack; however, in four of those patients, vestibular evoked myogenic potentials returned to normal after 48 hours. These authors postulated that abnormal vestibular evoked myogenic potentials were due to saccular hydrops affecting oscillation of the endolymph, whereas the reappearance of vestibular evoked myogenic potentials could be attributed to drainage of the saccular hydrops.
Although most studies have focussed on amplitude changes, recent reports indicate that threshold is probably a more reliable measure of vestibular evoked myogenic potential changes in Ménière's disease. 14, 15 Lin et al. 15 reported elevated mean vestibular evoked myogenic potential thresholds in affected ears and also, to a lesser extent, in contralateral asymptomatic ears, compared with normal controls. They concluded that vestibular evoked myogenic potentials could be used to predict contralateral ear involvement and eventual bilateral Ménière's disease.
The distinct characteristics of vestibular evoked myogenic potentials in acute and stable Mé niè re's disease are unknown. Therefore, this study examined vestibular evoked myogenic potentials in normal subjects and in patients with Mé niè re's disease, and also compared results for patients in the acute and stable phases of the disease.
Materials and methods

Subjects
Twenty patients who fulfilled the American Academy of Otolaryngology-Head and Neck Surgery 1 criteria for Mé niè re's disease, and who attended a tertiary neuro-otology clinic at the National Hospital for Neurology and Neurosurgery, London, were recruited for the study. All patients were interviewed to obtain a full clinical history and underwent a full clinical neuro-otological examination. The acute (exacerbation) group (11 patients) consisted of those who had had an attack in the preceding three months and were still symptomatic. The stable (remission) group (nine patients) had been free of attacks and symptoms for more than three months. Eighteen healthy volunteers (36 ears) aged between 18 and 60 years, with no history of neurological or otological disease, acted as controls.
The study was approved by the joint ethics committee of the National Hospital for Neurology and Neurosurgery and the Institute of Neurology.
Methods Audiovestibular tests. Pure tone audiometry was performed in all subjects. 16 The patients also underwent immitance audiometry, 16 Recording of vestibular evoked myogenic potentials. The sternocleidomastoid muscle was used as the target muscle. Subjects were tested while laying on a couch with the head rest adjusted 308 to the horizontal plane. Surface electromyography (EMG) was recorded by attaching Ag/AgCl electrodes on the mid-point of the sternocleidomastoid muscle (active), the mid-clavicle (negative) and the upper sternum (ground). From the recumbent position, subjects were instructed to lift their head up, in order to activate both sternocleidomastoid muscles symmetrically; a 500 Hz short tone burst (1 ms rise and fall, 2 ms plateau) was then delivered via TDH 49 calibrated headphones (Telephonics Corporation, New York, New York, USA), mono-aurally at a rate of 4.7 Hz, using the Medelec Synergy EMG/EP system (Oxford Instruments Limited, Surrey, UK). Tone bursts instead of clicks were used because the former involved less scatter of energy at suprathreshold level. A frequency of 500 Hz was used because this is the frequency reported to best differentiate normal from abnormal responses at threshold. 19 Electromyographic signals were amplified, band pass filtered between 20 and 2000 Hz, and sampled for 100 ms. Two hundred stimuli were averaged for each test run. The stimulus was delivered at 130 dBSPL to elicit the initial positive (p13) and negative (n23) waves ipsilateral to the stimulus (Figure 2) . The stimulus was then reduced in 5 dB steps and the minimum intensity required to elicit a p13-n23 response was taken to be the threshold of stimulation, designated T vestibular evoked myogenic potential. For each p13-n23 waveform, the peak-to-peak amplitude of the unrectified EMG was measured, as was the amplitude of the rectified EMG which reflected the degree of muscle activation. The latencies of p13 and n23 were measured and the interaural amplitude difference and ratio, as well as the interaural threshold difference and ratio, were computed.
The Statistical Package for the Social Sciences version 11 software (SPSS Inc, Chicago, Illinois, USA) was used for data analyses. The Student t-test was used to compare the results of the two patient groups, side-to-side differences, and differences between affected ears and control ears.
Comparisons of the results for the three subject groups were performed using one-way analysis of variance, with Bonferroni corrections for multiple comparisons. A significance level of 0.05 was used.
Results and analysis
The study included 12 female and six male controls with a mean age of 34.1 years (standard deviation (SD), 5.9 years; range, 26-49 years).
The characteristics of the patients are summarised in Table I . The mean age of the Mé niè re's disease patients was 48.5 years (SD, 11.3 years; range, 20 -61 years) and their median duration of illness was 4.5 years (range, 1-22 years). There were 10 women and 10 men. Eleven (55 per cent) patients had acute Mé niè re's disease and nine (45 per cent) had stable disease. In 11 (55 per cent) and nine (45 per cent) patients, the affected side was the left and right, respectively. According to the American Academy of Otolaryngology -Head and Neck Surgery criteria, 16 (80 per cent) were classified as having definite Mé niè re's disease, whereas two (10 per cent) each had possible and probable disease.
Four patients had normal caloric test responses, and one patient did not undergo the test because of an in situ grommet. The remaining patients had significant canal paresis in the affected ear, ranging between 8 and 100 per cent (normal canal paresis, for this department, was less than 8 per cent) ( Table I) .
Vestibular evoked myogenic potential results
The mean + SD threshold ( T vestibular evoked myogenic potential) for the controls (36 ears) was 116 + 7.7 dBSPL (+104.5 dBnHL). Vestibular evoked myogenic potentials were present in 13 (65 per cent) of the 20 affected ears. Of the seven (35 per cent) affected ears without a measurable vestibular evoked myogenic potential, two had acute disease and five had stable disease. Thus, vestibular evoked myogenic potentials were recorded in 81 per cent of the acute group but in only 44 per cent of the stable group. There was no correlation between the duration of Mé niè re's disease and the presence or absence of vestibular evoked myogenic potentials. The mean + SD T vestibular evoked myogenic potential for the affected ears in the acute and stable groups were respectively 118 + 7.9 dBSPL and 120 + 4.0 dBSPL. The same parameter in nonaffected patient ears was 117 + 5.3 dBSPL. There was no statistical difference in T vestibular evoked myogenic potential between acute and stable patients, control ears and affected ears, and control ears and non-affected ears (Table II) .
Twelve patients underwent vestibular evoked myogenic potential testing for both sides (affected and non-affected). Of these, vestibular evoked myogenic potentials were absent bilaterally in three, absent on the diseased side only in two and absent on the nondiseased side in a further two patients. Thus, in five patients, vestibular evoked myogenic potentials were absent in the non-affected ear. The mean + SD p13 and n23 latencies at threshold in the controls were respectively 15 + 2.2 ms and 23 + 2.5 ms. Statistically, these results did not differ from the respective results for the affected ears in the acute group (15.7 + 0.9 ms and 23.7 + 0.9 ms), the stable group (15.3 + 2.0 ms and 24.2 + 1.9 ms) or the non-affected Ménière's disease ears (15.1 + 0.8 ms and 23.6 + 1.1 ms). Although absolute latencies in the patients were within normal limits, p13 latency was shorter with longer duration of Ménière's disease (R ¼ 2 0.73; p ¼ 0.004) (Figure 3) .
The mean + SD corrected amplitudes (the ratio of tonic EMG and amplitude) did not differ between groups, being 1.7 + 0.5, 1.9 + 0.5 and 2.5 + 1.1 for normal controls, acute ears and stable affected ears, respectively. The mean + SD interaural amplitude difference ratios (i.e. right to left amplitude difference divided by the sum of amplitudes) for controls and for acute and stable Mé niè re's disease affected ears were respectively 0. 
Discussion
This study compared vestibular evoked myogenic potential characteristics at threshold levels in patients with acute and stable Mé niè re's disease, using 500 Hz short tone burst stimuli. It has been widely reported that vestibular evoked myogenic potentials are frequency-sensitive in healthy individuals, as reflected in the 'frequency tuning curves'. Although Todd et al. 20 reported maximum vestibular evoked myogenic potential amplitude responses of between 300 and 350 Hz, the optimum frequency of the tone burst in healthy adults has been reported to be 500 Hz. 19, 21 In the study by Rauch et al., 19 poorer tuning was apparent in Mé niè re's disease patients at 500 Hz, and this was the frequency that best differentiated normal from diseased subjects. However, this 'best' frequency can lie between 500 and 1000 Hz 22 or between 500 and 700 Hz. 23 The In this study, T vestibular evoked myogenic potential was 116 + 7.7 dBSPL. The threshold vestibular evoked myogenic potential response in healthy adults ranges between 110 19 and 114.4 dBSPL.
22
The apparent differences may be due to differences in methodology. Studies reporting threshold changes in Mé niè re's disease are few. In contrast to the present study, in which there was no statistically significant T vestibular evoked myogenic potential difference between the ears of healthy volunteers and the affected and nonaffected ears of Mé niè re's disease patients, Rauch et al. 19 reported significantly elevated thresholds both in the affected and unaffected ears of Mé niè re's disease patients, compared with normal subjects. Lin et al., 15 from the same centre, reported an elevated mean vestibular evoked myogenic potential threshold in affected ears and also, to a lesser extent, in the contralateral asymptomatic ears, compared with normal controls. These authors concluded that the vestibular evoked myogenic potential threshold can be used to predict contralateral ear involvement and eventual bilateral Mé niè re's disease; they also emphasised the importance of multifrequency testing to study the frequency tuning characteristics in Mé niè re's disease.
In the present study, the vestibular evoked myogenic potential parameter that best differentiated the three groups was the interaural amplitude difference ratio. This ratio was 0.10 + 0.22 for controls, 20.15 + 0.22 for acute Mé niè re's disease affected ears and 0.54 + 0.33 for stable Mé niè re's disease affected ears. In the literature, there is no information on values using tone burst, but for clickevoked vestibular evoked myogenic potential, a normal interaural amplitude difference ratio range of 0.14 + 0.11 (mean + 1 SD) has been reported. 9 These same authors reported a positive correlation between interaural amplitude difference ratios and the stage of disease, i.e. the higher the stage, the higher the ratio. This was not the case in our study, probably due to the small sample size. We found that the interaural amplitude difference ratio was significantly higher in stable disease when compared with acute disease ( p ¼ 0.007) and with controls ( p ¼ 0.05). Although the number of patients in our study was small, the interaural amplitude difference ratio appears to be a promising parameter for monitoring Mé niè re's disease progression; further research is needed to refine its clinical utility.
Rauch et al. 14 reported that, in unilateral Mé niè re's disease, the interaural threshold difference correctly assigned side-of-disease in 85 per cent of cases. In this study, the interaural threshold difference did not vary between groups, probably due to differences in methodology and sample size.
. Vestibular evoked myogenic potentials are generated by saccular afferents in response to loud acoustic stimuli . Ipsilateral vestibular evoked myogenic potentials specifically assess saccular function . The saccule is the commonest vestibular site affected by Mé niè re's disease . In this study, the interaural amplitude difference ratio appeared to be a valuable vestibular evoked myogenic potential parameter that differentiated between acute and stable Mé niè re's disease . The interaural amplitude difference ratio may be useful in monitoring the clinical course of Mé niè re's disease
Latencies were normal in all groups. However, the p13 latency correlated negatively with the duration of Mé niè re's disease (R ¼ 20.73; p ¼ 0.004). The p13 latency was shorter with a longer duration of Mé niè re's disease. The reason for this finding is not clear. Latency changes are believed to reflect changes within the central conducting pathways of the vestibular evoked myogenic potential reflex. Latency has been found to be stable in a variety of peripheral vestibular disorders, including Mé niè re's disease. 11, 24, 25 Murofushi et al. 24 also reported prolonged p13 latency both in patients with multiple sclerosis and in those with a large vestibular schwannoma compressing the brainstem. They concluded that lesions within the brainstem pathway of the vestibulospinal tract are a prerequisite for the prolongation of p13. Similar findings were reported by Alpini et al., 26 who attributed the prolonged latencies in multiple sclerosis to demyelination, either of the primary afferent axons at the root entry zone or of secondary vestibulospinal tract axons. However, a few studies have reported prolonged p13 and n23 latencies in Mé niè re's disease, attributed to a high endolymphatic pressure in the saccule, impairing sound transmission. 9, 27 One possible explanation for the latency findings in this study could be retrograde degeneration in Scarpa's ganglion and the vestibular nerve, reducing the conduction velocity of the vestibular evoked myogenic potential reflex as the disease progresses, although there are FIG. 3 Correlation between p13 latency and Mé niè re's disease duration.
V OSEI-LAH, B CERANIC, L M LUXON conflicting reports as to whether this occurs in Mé niè re's disease. Spoendlin et al. 28 and Kitamura et al. 29 reported degeneration and decrease in vestibular nerve fibres, whereas Ylikoski et al. 30 and Kitamura et al. 31 found no such evidence.
Conclusion
The recording of vestibular evoked myogenic potentials is an emerging, non-invasive vestibular function test which can be applied to Mé niè re's disease. The interaural amplitude difference ratio appears to be a valuable parameter which can be used to monitor the clinical course of the disease, and in particular to identify the acute phase of Mé niè re's disease so as to guide appropriate treatment. However, in order to refine its clinical utility and to recommend its routine use in Mé niè re's disease, large, prospective, controlled, longitudinal vestibular evoked myogenic potential studies (during different phases of Mé niè re's disease) are required, in order to determine the sensitivity and specificity of the various vestibular evoked myogenic potential parameters.
